These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6394584)

  • 1. Anabolic steroids in severe chronic renal failure.
    Malhotra KK; Suresh KR; Bansal RC
    J Assoc Physicians India; 1984 Oct; 32(10):878-80. PubMed ID: 6394584
    [No Abstract]   [Full Text] [Related]  

  • 2. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 3. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
    Williams JS; Stein JH; Ferris TF
    Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
    Johansen KL
    Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double blind study of histidine therapy of anemia in patients with chronic renal failure treated by hemodialysis].
    Pérez Mijares R; Rocha E; Mazo E; Vidaur F; Lasa R; López de Novales E
    Rev Clin Esp; 1978 Oct; 151(1):39-42. PubMed ID: 368904
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of androgens in chronic renal failure patients on maintenance hemodialysis.
    Alexander MR
    Am J Hosp Pharm; 1976 Mar; 33(3):242-8. PubMed ID: 769543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin levels, quality of life, and survival.
    Sadler JH; Meyer KB
    Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgenic steroids in anemia of chronic renal failure.
    Wombolt DG; Oller NS
    Va Med Mon (1918); 1974 Oct; 101(10):846-8. PubMed ID: 4456865
    [No Abstract]   [Full Text] [Related]  

  • 10. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
    Berns JS; Rudnick MR; Cohen RM
    Am J Kidney Dis; 1991 Jul; 18(1):143. PubMed ID: 2063850
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
    Barton Pai A; Chretien C; Lau AH
    Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
    Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
    J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic uremic anemia in patients undergoing periodic extracorporeal dialysis with large doses of anabolic androgens].
    Pentangelo C; Mazza L; Scoppa F
    Rass Int Clin Ter; 1971 Oct; 51(20):1268-76. PubMed ID: 5137470
    [No Abstract]   [Full Text] [Related]  

  • 14. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
    Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
    Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure.
    Silverberg D; Wexler D; Blum M; Schwartz D; Iaina A
    Nephrol Dial Transplant; 2004 Apr; 19(4):1021. PubMed ID: 15031380
    [No Abstract]   [Full Text] [Related]  

  • 17. Epoetin-induced pure red cell aplasia successfully treated with androgens.
    Sánchez de la Nieta MD; Caparrós G; Rivera F
    J Nephrol; 2006; 19(2):220-1. PubMed ID: 16736425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
    Teruel JL; Marcen R; Navarro-Antolin J; Aguilera A; Fernandez-Juarez G; Ortuño J
    J Am Soc Nephrol; 1996 Jan; 7(1):140-4. PubMed ID: 8808121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.